Connor, Clark & Lunn Investment Management (CC&L)’s Black Diamond Therapeutics BDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$528K Sell
2024
Q3
$1.24M Sell
2024
Q2
$1.34M Sell
2024
Q1
$1.59M Buy
2022
Q4
Sell
2022
Q3
$140K Buy
2022
Q2
$30K Buy